Mary Beth Harler insider trades: IGM Biosciences (IGMS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mary reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | IGMS | ↓ Sell | 14,501 | $1.27 | $18K | Direct | Jul 25, 2025 (2d) |
| Jun 16, 2025 | IGMS | ↓ Sell | 1,522 | $1.20 | $2K | Direct | Jun 20, 2025 (4d) |
| Mar 14, 2025 | IGMS | ↓ Sell | 7,329 | $1.23 | $9K | Direct | Mar 18, 2025 (4d) |
| Dec 16, 2024 | IGMS | ↓ Sell | 1,708 | $7.48 | $13K | Direct | Dec 18, 2024 (2d) |
| Sep 13, 2024 | IGMS | ↓ Sell | 1,487 | $11.54 | $17K | Direct | Sep 17, 2024 (4d) |
| Jun 14, 2024 | IGMS | ↓ Sell | 1,570 | $7.58 | $12K | Direct | Jun 18, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mary Beth Harler's insider trades
Mary Beth Harler is Chief Executive Officer at IGM Biosciences (IGMS). Since Jun 14, 2024, Mary has reported no open-market purchases and 6 sales worth $71K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares returned to the company (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IGMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.